ArticleCancers2025

Usefulness of the Early Increase of Peripheral Blood Lymphocyte Count in Predicting Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma Treated with Durvalumab Plus Tremelimumab.

Yuichi Honma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.